MedTrace Logo

Prescribe to Save Lives

NCT03175640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 294

Last updated 2020-12-21

No results posted yet for this study

Summary

The U.S. is in the midst of an epidemic of opioid overdose deaths. The common use of opioids among persons living with HIV, along with their common use of benzodiazepines, has resulted in high rates of opioid overdose among this population. This study will test the implementation of evidence-based training, mentoring, technical support, and academic detailing to encourage HIV physicians to adopt evidence-based interventions to reduce overdose risk and treat opioid addiction.

Conditions

  • Opioid-Related Disorders
  • Drug Overdose

Interventions

BEHAVIORAL

Implementation intervention

The implementation intervention includes peer-to-peer training, post-training outreach, proactive expert support, and assistance with addressing environmental barriers.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • The Miriam Hospital

    collaborator OTHER

  • Boston Medical Center

    collaborator OTHER

  • Rhode Island Hospital

    collaborator OTHER

  • Baystate Medical Center

    lead OTHER

Principal Investigators

  • Peter D Friedmann, MD, MPH · University of Massachusetts Medical School - Baystate

  • Josiah D Rich, MD, MPH · The Miriam Hospital

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-12
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03175640 on ClinicalTrials.gov